Westfield Capital Management CO LP Pacific Biosciences Of California, Inc. Transaction History

Westfield Capital Management CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $7.24 Million - $17.9 Million	-858,583 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$19.26 - $30.08 $16.9 Million - $26.4 Million	-878,542 Reduced 50.57%	858,583 $17.6 Million
Q3 2021 Nov 12, 2021	BUY	$24.86 - $35.02 $1.3 Million - $1.83 Million	52,167 Added 3.1%	1,737,125 $44.4 Million
Q2 2021 Aug 10, 2021	BUY	$22.3 - $36.02 $6.43 Million - $10.4 Million	288,362 Added 20.65%	1,684,958 $58.9 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $36.8 Million - $71.4 Million	1,396,596 New	1,396,596 $46.5 Million

258

234M

1.02M

965K

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $393M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.